Concepedia

Rachel A. Toroni

RA

7

Publications

527

Citations

7

H-Index

2010

Active since

Affiliations

University of Washington(Current)

Howard Hughes Medical Institute

Indiana University School of Medicine

Indiana University – Purdue University Indianapolis

University of California, Los Angeles

Rachel A. Toroni is an author at University of Washington specializing in tumor biology, medicine, and cell biology.

Top concepts

Publications per year

2010–2014

7

Publications

7

WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors

Jamie N. Anastas, Rima M. Kulikauskas, Tigist Y. Tamir et al. · Journal of Clinical Investigation · 2014 · 171 citations · Full text

, , +14

Wnt/β-Catenin Signaling and AXIN1 Regulate Apoptosis Triggered by Inhibition of the Mutant Kinase BRAF <sup>V600E</sup> in Human Melanoma

Travis L. Biechele, Rima M. Kulikauskas, Rachel A. Toroni et al. · Science Signaling · 2012 · 155 citations

Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models

Yesim Gökmen‐Polar, Yi Liu, Rachel A. Toroni et al. · Breast Cancer Research and Treatment · 2012 · 79 citations

, , +9

Dual targeting of EphA2 and ER restores tamoxifen sensitivity in ER/EphA2-positive breast cancer

Yesim Gökmen‐Polar, Rachel A. Toroni, Barbara A. Hocevar et al. · Breast Cancer Research and Treatment · 2010 · 45 citations

, , +10

WLS inhibits melanoma cell proliferation through the β‐catenin signalling pathway and induces spontaneous metastasis

Pei‐Tzu Yang, Jamie N. Anastas, Rachel A. Toroni et al. · EMBO Molecular Medicine · 2012 · 35 citations · Full text

, , +9

Rows per page

1–5 of 7